美国的肤色主义态度和皮肤美白剂的使用。

Q2 Medicine International Journal of Women''s Dermatology Pub Date : 2023-07-13 eCollection Date: 2023-10-01 DOI:10.1097/JW9.0000000000000092
Karishma Daftary, Sneha Poondru, Nina Patel, Maxwell Shramuk, Lutfiyya Muhammad, Roopal V Kundu
{"title":"美国的肤色主义态度和皮肤美白剂的使用。","authors":"Karishma Daftary,&nbsp;Sneha Poondru,&nbsp;Nina Patel,&nbsp;Maxwell Shramuk,&nbsp;Lutfiyya Muhammad,&nbsp;Roopal V Kundu","doi":"10.1097/JW9.0000000000000092","DOIUrl":null,"url":null,"abstract":"<p><p>Skin lightening (SL) is a practice involving the use of chemicals to lighten the skin that is more common among skin of color (SOC) individuals, particularly women, and can lead to adverse health consequences.</p><p><strong>Objective: </strong>In this study, we examine SL habits, including both general lightening and lightening for the treatment of a skin condition, among SOC individuals in the United States and the role of colorism in motivating these behaviors.</p><p><strong>Methods: </strong>A cross-sectional survey was administered to SOC individuals through ResearchMatch, an online national health registry. Demographics, rates of SL, SL habits, and perceived colorism among SL users and nonusers were collected and analyzed with <i>χ<sup>2</sup></i>, Fisher's exact, Analysis of variance (ANOVA), Spearman correlation, and <i>t</i> tests.</p><p><strong>Results: </strong>A total of 455 participants completed the survey. Ninety-seven participants (21.3%) reported using SL agents: 73.2% (71/97) used SL agents for the treatment of a skin condition and 26.8% (26/97) used the products for general SL. Only 22.6% (22/97) of SL users consulted a medical provider before using the products. Forty-four participants (45.4%) were unaware of their SL product ingredients, and 35.1% (34/97) reported using hydroquinone-based products. Composite colorism scores were significantly higher in SL users than nonusers (20.03 vs 18.20; <i>P</i> < .001).</p><p><strong>Limitations: </strong>This study used self-reported racial/ethnic groups to characterize those with SOC rather than assessing actual skin tones of participants, which could have led to variability.</p><p><strong>Conclusion: </strong>SL among SOC individuals is prevalent in the U.S. and poses a health risk, as many SL users are unaware of product ingredients, do not consult a medical provider before use, and have access to potentially unsafe formulations. Dermatologists should address skin tone and pigmentary concerns with their SOC patients.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"9 3","pages":"e092"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4b/26/jw9-9-e092.PMC10344531.pdf","citationCount":"1","resultStr":"{\"title\":\"Colorism attitudes and use of skin lightening agents in the United States.\",\"authors\":\"Karishma Daftary,&nbsp;Sneha Poondru,&nbsp;Nina Patel,&nbsp;Maxwell Shramuk,&nbsp;Lutfiyya Muhammad,&nbsp;Roopal V Kundu\",\"doi\":\"10.1097/JW9.0000000000000092\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Skin lightening (SL) is a practice involving the use of chemicals to lighten the skin that is more common among skin of color (SOC) individuals, particularly women, and can lead to adverse health consequences.</p><p><strong>Objective: </strong>In this study, we examine SL habits, including both general lightening and lightening for the treatment of a skin condition, among SOC individuals in the United States and the role of colorism in motivating these behaviors.</p><p><strong>Methods: </strong>A cross-sectional survey was administered to SOC individuals through ResearchMatch, an online national health registry. Demographics, rates of SL, SL habits, and perceived colorism among SL users and nonusers were collected and analyzed with <i>χ<sup>2</sup></i>, Fisher's exact, Analysis of variance (ANOVA), Spearman correlation, and <i>t</i> tests.</p><p><strong>Results: </strong>A total of 455 participants completed the survey. Ninety-seven participants (21.3%) reported using SL agents: 73.2% (71/97) used SL agents for the treatment of a skin condition and 26.8% (26/97) used the products for general SL. Only 22.6% (22/97) of SL users consulted a medical provider before using the products. Forty-four participants (45.4%) were unaware of their SL product ingredients, and 35.1% (34/97) reported using hydroquinone-based products. Composite colorism scores were significantly higher in SL users than nonusers (20.03 vs 18.20; <i>P</i> < .001).</p><p><strong>Limitations: </strong>This study used self-reported racial/ethnic groups to characterize those with SOC rather than assessing actual skin tones of participants, which could have led to variability.</p><p><strong>Conclusion: </strong>SL among SOC individuals is prevalent in the U.S. and poses a health risk, as many SL users are unaware of product ingredients, do not consult a medical provider before use, and have access to potentially unsafe formulations. Dermatologists should address skin tone and pigmentary concerns with their SOC patients.</p>\",\"PeriodicalId\":53478,\"journal\":{\"name\":\"International Journal of Women''s Dermatology\",\"volume\":\"9 3\",\"pages\":\"e092\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4b/26/jw9-9-e092.PMC10344531.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Women''s Dermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/JW9.0000000000000092\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/10/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Women''s Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/JW9.0000000000000092","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

皮肤美白(SL)是一种使用化学物质来淡化皮肤的做法,在有色人种(SOC)中更为常见,尤其是女性,可能会导致不利的健康后果。目的:在这项研究中,我们调查了美国SOC个体的SL习惯,包括一般的美白和治疗皮肤病的美白,以及肤色在激发这些行为中的作用。方法:通过在线国家健康登记处ResearchMatch对SOC个体进行横断面调查。收集SL使用者和非使用者的人口学数据、SL发生率、SL习惯和感知色度,并采用χ2、Fisher精确、方差分析(ANOVA)、Spearman相关性和t检验进行分析。结果:共有455名参与者完成了调查。97名参与者(21.3%)报告使用SL制剂:73.2%(71/97)使用SL制剂治疗皮肤病,26.8%(26/97)将该产品用于一般SL。只有22.6%(22/97)的SL使用者在使用该产品前咨询了医疗机构。44名参与者(45.4%)不知道他们的SL产品成分,35.1%(34/97)报告使用了氢醌类产品。SL使用者的综合肤色得分明显高于非使用者(20.03 vs 18.20;P<.001)。局限性:这项研究使用自我报告的种族/族裔群体来表征SOC患者,而不是评估参与者的实际肤色,这可能会导致变异。结论:SL在SOC人群中在美国很普遍,并构成健康风险,因为许多SL使用者不知道产品成分,使用前不咨询医疗服务提供者,并且可以获得潜在的不安全配方。皮肤科医生应解决SOC患者的肤色和色素问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Colorism attitudes and use of skin lightening agents in the United States.

Skin lightening (SL) is a practice involving the use of chemicals to lighten the skin that is more common among skin of color (SOC) individuals, particularly women, and can lead to adverse health consequences.

Objective: In this study, we examine SL habits, including both general lightening and lightening for the treatment of a skin condition, among SOC individuals in the United States and the role of colorism in motivating these behaviors.

Methods: A cross-sectional survey was administered to SOC individuals through ResearchMatch, an online national health registry. Demographics, rates of SL, SL habits, and perceived colorism among SL users and nonusers were collected and analyzed with χ2, Fisher's exact, Analysis of variance (ANOVA), Spearman correlation, and t tests.

Results: A total of 455 participants completed the survey. Ninety-seven participants (21.3%) reported using SL agents: 73.2% (71/97) used SL agents for the treatment of a skin condition and 26.8% (26/97) used the products for general SL. Only 22.6% (22/97) of SL users consulted a medical provider before using the products. Forty-four participants (45.4%) were unaware of their SL product ingredients, and 35.1% (34/97) reported using hydroquinone-based products. Composite colorism scores were significantly higher in SL users than nonusers (20.03 vs 18.20; P < .001).

Limitations: This study used self-reported racial/ethnic groups to characterize those with SOC rather than assessing actual skin tones of participants, which could have led to variability.

Conclusion: SL among SOC individuals is prevalent in the U.S. and poses a health risk, as many SL users are unaware of product ingredients, do not consult a medical provider before use, and have access to potentially unsafe formulations. Dermatologists should address skin tone and pigmentary concerns with their SOC patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.70
自引率
0.00%
发文量
52
审稿时长
18 weeks
期刊介绍: The IJWD publishes articles pertaining to dermatologic medical, surgical and cosmetic issues faced by female patients and their families. We are interested in original research articles, review articles, unusual case reports, new treatments, clinical trials, education, mentorship and viewpoint articles. Articles dealing with ethical issues in dermatology and medical legal scenarios are also welcome.Very important articles will have accompanying editorials. Topics which our subsections editors look forward to welcoming include: Women’s Health Oncology, Surgery and Aesthetics Pediatric Dermatology Medical Dermatology Society.
期刊最新文献
Need for individualized counseling regarding psoriasis systemic therapy in women of childbearing age: analysis of the PsoFem study at the University Medical Center Hamburg. Case reports on hand prejuvenation: clinical outcomes in middle-aged women with hyaluronic acid filler plus lidocaine. Clinical and demographic characteristics of frontal fibrosing alopecia in a dermatology referral center in Bogota, Colombia: a descriptive cross-sectional study. What do you need to know when preparing to give a talk at an international dermatology conference? Insights and practical recommendations. Botulinum toxin treatment of refractory vaginismus: a prospective study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1